Aurora Spine Corporation Announces Second Quarter Fiscal 2023 Financial Results
CARLSBAD, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its second quarter fiscal 2023 ended June 30, 2023. All figures are in U.S. dollars.
- Management to host conference call for investors in coming week, details to follow -
CARLSBAD, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its second quarter fiscal 2023 ended June 30, 2023. - Total operating expenses were $2.514 million for the second quarter of 2023, compared to $2.368 million in the second quarter of 2022.
- Net loss was $(0.482) million for the second quarter of 2023, compared to the second quarter of 2022 with a loss of $(0.160) million.
- Basic and diluted net (loss) income per share was $(0.01) per share in the second quarter of 2023 and $(0.00) per share for the second quarter of 2022.